Ovid Therapeutics Inc. (NASDAQ: OVID)
$1.04
+0.1010 ( +10.76% ) 622.1K
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.
Market Data
Open
$1.04
Previous close
$0.94
Volume
622.1K
Market cap
$73.78M
Day range
$0.93 - $1.05
52 week range
$0.68 - $4.14
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Jul 01, 2024 |
8-k | 8K-related | 13 | Jun 28, 2024 |
8-k | 8K-related | 13 | Jun 17, 2024 |
8-k | 8K-related | 11 | Jun 07, 2024 |
8-k | 8K-related | 15 | May 14, 2024 |
10-q | Quarterly Reports | 103 | May 14, 2024 |
ars | Annual reports | 1 | Apr 24, 2024 |
def | Proxies and info statements | 21 | Apr 24, 2024 |
4 | Insider transactions | 1 | Mar 20, 2024 |
8-k | 8K-related | 16 | Mar 08, 2024 |